Delivery Order SPE2DB20D1100-SPE2DB24FC4Z4
Award Date
6/28/24
Potential Completion Date
7/22/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Envarsus XR 4 mg tablet. The award, valued at $6,461.32, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 10, 2024, with a completion date of July 2, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation....
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 1 mg tablets to the U.S. government. The contract, valued at $1,216.11, is a delivery order with a firm fixed price. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 1, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor on...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Envarsus XR 4 mg tablets. The $1,615.33 firm fixed-price delivery order has an ultimate completion date of October 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Envarsus XR 1 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $1,465.68 with a completion date of September 9, 2024. The contract has no set-aside designation. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.95, is for the delivery of Envarsus XR 4 mg tablets. The contract is a firm fixed-price delivery order with a completion date of May 7, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Envarsus XR 4 mg tablets. The contract, valued at $19,383.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of September 20, 2024. This delivery order contract is a firm fixed price arrangement. Amerisourcebergen has been a significant supplier of pharmaceutical and medical products to various government agencies, including...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD), with a ceiling value of $1,465.68. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 0.75 mg tablets. The contract has a ceiling value of $2,128.84 and a period of performance ending on September 10, 2024. It is a Firm Fixed Price contract with no set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of the pharmaceutical drug Envarsus XR 4 mg tablets, with a firm fixed price ceiling value of $6,461.32 and a period of performance through April 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,288.86 and a performance period extending through May 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen...